Platelet-Rich Plasma for the Treatment of Ocular Surface Disease in Animals: A Systematic Review

    January 2025 in “ Veterinary Medicine International
    Daniel Uribe, Catalina López, Jorge U. Carmona
    TLDR PRP shows promise for eye disease in animals but needs more research before being standard care.
    This systematic review assesses the efficacy and safety of platelet-rich plasma (PRP) for treating ocular surface diseases in animals, focusing on corneal ulcers and keratoconjunctivitis sicca. Analyzing 14 studies involving rabbits, dogs, cats, and rats, PRP was found to improve corneal healing, reduce edema, vascularization, pain, and inflammation. However, the studies had high bias risk, small sample sizes (median n=20), and inconsistent PRP protocols, limiting definitive conclusions. While PRP shows promise, it is not yet recommended as standard care. Future research should standardize PRP preparation and conduct randomized controlled trials to better assess its therapeutic potential.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Research

    1 / 1 results